Altered immune and metabolic molecular pathways drive islet cell dysfunction in human type 1 diabetes
Authors:
- Xiao-Qing DaiXDXiao-Qing Dai
- Robert C. JonesRJRobert C. Jones
- Aliya F. SpigelmanASAliya F. Spigelman
- Hannah M. MummeyHMHannah M. Mummey
- Jessica D. EwaldJEJessica D. Ewald
- Cara E. EllisCECara E. Ellis
- James G. LyonJLJames G. Lyon
- Nancy SmithNSNancy Smith
- Austin BautistaABAustin Bautista
- Norma F. NeffNNNorma F. Neff
Open Access
- 30 September 2025
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (23)
Abstract
Type 1 diabetes (T1D) is characterized by the autoimmune destruction of most insulin-producing β cells, along with dysregulated glucagon secretion from pancreatic α cells. We conducted an integrated analysis that combines electrophysiological and transcriptomic profiling, along with machine learning, of islet cells from T1D donors. The few surviving β cells exhibit altered electrophysiological properties and transcriptomic signatures indicative of increased antigen presentation, metabolic reprogramming, and impaired protein translation. In α cells, we observed hyperresponsiveness and increased exocytosis, which are associated with upregulated immune signaling, disrupted transcription factor localization, and lysosome homeostasis, as well as dysregulation of mTORC1 complex signaling. Notably, key genetic risk signals for T1D were enriched in transcripts related to α cell dysfunction, including MHC class I, which were closely linked with α cell dysfunction. Our data provide what we believe are novel insights into the molecular underpinnings of islet cell dysfunction in T1D, highlighting pathways that may be leveraged to preserve residual β cell function and modulate α cell activity. These findings underscore the complex interplay between immune signaling, metabolic stress, and cellular identity in shaping islet cell phenotypes in T1D.Keywords
Funding Information
- Canadian Institutes of Health Research (186226)
- National Institutes of Health (DK120447,DK105554,DK138512,HG012059,UC4-DK-112217,U01-DK-123594,UC4-DK-112232,U01-DK-123716)
- JDRF (2-SRA-2019-698-S-B)
- Knut och Alice Wallenbergs Stiftelse (n/a)
- Vetenskapsrådet (2021-05109)
This publication has 104 references indexed in Scilit:
- Non-canonical NF-κB signaling pathwayCell Research, 2010
- Glucose-responsive beta cells in islets isolated from a patient with long-standing type 1 diabetes mellitusDiabetologia, 2010
- Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist StudyDiabetes, 2010
- Immunopathology of the human pancreas in type-I diabetesSeminars in Immunopathology, 2010
- α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma RemainsEndocrine Reviews, 2007
- Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patientsDiabetes/Metabolism Research and Reviews, 2004
- Insulin Secretion in Type 1 DiabetesDiabetes, 2004
- Negative Regulators of Cytokine SignalingInternational Journal of Hematology, 2001
- Function of pancreatic islets isolated from a type 1 diabetic patient.Diabetes Care, 2000
- Human pancreatic islet function at the onset of Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1993